HEPACAM2 activators pertain to a class of chemical compounds that are known to interact with and modulate the activity of the HEPACAM2 protein, which is encoded by the HEPACAM2 gene. This protein belongs to a family of cell adhesion molecules that have critical roles in cellular processes, such as cell adhesion, migration, and communication. The precise molecular mechanisms through which HEPACAM2 exerts its functions are complex and involve a variety of intracellular signaling pathways. Activators of this protein are molecules that enhance its activity or increase its expression, thereby amplifying its normal cellular functions. They typically bind to the protein or its associated receptors and can induce conformational changes that promote its activation or stabilize its active form. The design and development of these activators often stem from an in-depth understanding of the protein's structure and the biochemical pathways it influences.
The discovery and characterization of HEPACAM2 activators are grounded in the field of biochemistry and molecular biology. These activators may be identified through high-throughput screening of chemical libraries or by studying the natural ligands and modulators of the HEPACAM2 protein. Once identified, HEPACAM2 activators are subjected to a series of biochemical assays to confirm their mode of action and to determine their specificity and efficacy in modulating the protein's activity. Such studies often involve the use of recombinant HEPACAM2 protein, genetically modified cell lines, and detailed analyses of the signaling pathways affected. The characterization of these compounds includes an assessment of their binding affinity, kinetics, and the elucidation of their interaction with the protein at the molecular level, often using techniques such as X-ray crystallography or NMR spectroscopy. Understanding how these activators influence HEPACAM2 function is crucial for elucidating the physiological roles of the protein and the cellular processes it regulates.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP activates PKA, which can phosphorylate substrates that modulate the cytoskeleton and cell adhesion, processes in which HEPACAM2 is directly involved. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts as a ligand for S1P receptors, modulating actin cytoskeleton reorganization and enhancing cell-cell adhesion, processes critical for HEPACAM2’s role in cell signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate inhibits several protein kinases, potentially reducing competitive signaling and indirectly enhancing HEPACAM2-mediated cell adhesion and signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which can influence the phosphorylation state of proteins involved in cell-cell junctions, thereby enhancing HEPACAM2’s function in cell adhesion. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, altering downstream AKT signaling. This modulation can lead to changes in cell adhesion dynamics, potentially enhancing HEPACAM2-mediated signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, shifting the balance of MAPK signaling. This alteration may enhance HEPACAM2’s activity by modulating its interactions with the cytoskeleton and cell adhesion molecules. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which can lead to changes in cytoskeletal dynamics and cell adhesion, processes where HEPACAM2 is implicated, thus potentially enhancing HEPACAM2 function. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid modulates gene expression and cell differentiation, which can indirectly enhance HEPACAM2’s role in cell adhesion and signaling during neurodevelopment. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin increases intracellular calcium levels, which can activate calcium-dependent signaling pathways, indirectly enhancing HEPACAM2’s role in cell-cell communication and adhesion. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 inhibits Rac1, a GTPase that regulates the actin cytoskeleton. Inhibition of Rac1 can modulate cell adhesion and morphology, potentially enhancing HEPACAM2 activity. | ||||||